Liver Biopsy System Market Pegged for Robust Expansion During 2025

Liver Biopsy is the removal of tissue sample from liver for diagnosis of liver disease in cases when blood tests and serology tests are not able to identify the cause. Conditions in which liver biopsy is required are alcoholic liver disease, chronic hepatitis, fatty liver disease, cirrhosis, autoimmune hepatitis, Wilson disease and others. It is also used to differentiate between cancerous and non-cancerous cells as CT scans and X-Rays can’t differentiate between these cells.

Request Report for TOC @ https://www.persistencemarketresearch.com/toc/14938

Recently, it is possible to use both techniques either by minimal invasiveness using the transjugular method or by the guidance of computed tomography, ultrasound, or laparoscopic and endoscopic ultrasound. The systems used in liver biopsy procedures include the Needle, Introducer sheath, catheters and instrument kits. The most common complication in the use of liver biopsy system is the pain as 75% of patients suffer some discomfort after liver biopsy.

According to Liver Foundation, more than 30 million people or one in ten million Americans are affected with some form of liver disease. Thus, there is a future probability for increase in the use of Liver Biopsy system for diagnosis.

Liver Biopsy System Market: Drivers & Restraints

Increase in awareness among people, cost effective biopsy devices and instruments is going to fuel the market. Increased prevalence of liver diseases worldwide demand the need of liver biopsies for detection. Some complications of liver biopsy such as Pleurisy, Perihepatitis, Intrahepatic hematoma, Bacterimia, Pulmonary bile embolism etc. can be a restraint for the liver biopsy systems’ market and people may switch to other alternatives available but by overcoming these complications through improved technology and skilled personnel, Liver biopsy will be the priority for diagnostic purposes because of more reliable results. Less risk of bleeding complications, post biopsy contra-indications and less painful approaches will be the growing trend in the market.

According to a study published in Oxford Academic in 2009, Hospital admission rates for chronic liver disease in UK increased by 71% in males and 43% in females over the study period. This rate is going to increase in the coming years because of increased prevalance of liver diseases globally due to increase consumption of alcohol, obesity, cholesterol, diabetes and viral pathogens thus fueling the liver biopsy systems market for diagnosis of the disease. Techniques available these days for liver tissue sampling include percutaneous liver biopsy, transjugular liver biopsy, laparoscopic liver biopsy, and transgastric liver biopsy. Moreover, liver transplants are also increased these days because of increased liver problems and improved medical facilities which in turn increase the need for liver biopsies. Huge capital investment by the key players and new innovations are required to stand in the market.

A geographic condition regarding the Liver Biopsy System Market, it has been segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. Better awareness, new technology and more reimbursement scenario in developed countries like North America and Europe shows the growth of Liver Biopsy System Market. Moreover, more alcohol consumption increases the risk of liver diseases in these regions and thus shows more developed market of Liver Biopsy Systems. Hepatitis C has shown an increasing prevalence in the regions of Middle East & Africa, thus showing the future increase in the use of Liver Biopsy system in these regions. Limiting factors such as lack of technical expertise, skilled interventional radiologist or physician, high instrument cost in less developed countries limits the market to grow and launch new products or technologies.

Some of the global key players in the Liver Biopsy System Market for manufacturing equipments, kits for diagnosis are Argon Medical Devices, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, C. R. Bard, Inc., Cook Medical, RI.MOS., Sterylab, Veran medical, Medtronic, INRAD Inc. and others.

Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/14938

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: www.persistencemarketresearch.com

This release was published on openPR.